Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
American Journal of Physiology. Renal Physiology|July 20, 2019
Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-KJia Yin, David J Wagner, Bhagwat Prasad, et al.International Journal of Pharmaceutics|April 3, 2020
A candidate drug administered subcutaneously to rodents as drug particles showing hepatic recirculation which influenced the sustained release processKalle Sigfridsson, Torbjörn Arvidsson, Aixiang Xue, et al.Molecular Pharmacology|July 18, 2018
Organic Cation Transporter 3 Facilitates Fetal Exposure to Metformin during PregnancyNora Lee, Mary F Hebert, David J Wagner, et al.Pharmaceutical Development and Technology|September 24, 2021
Experimental design, development and evaluation of extended release subcutaneous thermo-responsive <i>in situ</i> gels for small molecules in drug discoveryDivya Sharma, Faraj Atassi, Steve Cook, et al.Journal of Periodontology|June 2, 2007
Lysophosphatidic acid modulates the healing responses of human periodontal ligament fibroblasts and enhances the actions of platelet-derived growth factorD Roselyn Cerutis, Andrew C Dreyer, Matthew J Vierra, et al.Journal of Medicinal Chemistry|April 26, 2021
Fragment-Based Design of a Potent MAT2a Inhibitor and <i>in Vivo</i> Evaluation in an MTAP Null Xenograft ModelClaudia De Fusco, Marianne Schimpl, Ulf Börjesson, et al.RSC Medicinal Chemistry|June 16, 2025
Synthetic chemistry enabling the discovery and development of a series of pyrazoles as HPK1 inhibitorsAnthony J Metrano, Lucas A Morrill, Gayathri Bommakanti, et al.Journal of Medicinal Chemistry|February 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 InhibitorJason D Shields, David Baker, Amber Y S Balazs, et al.Pageof 2